282 related articles for article (PubMed ID: 17062922)
41. Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats.
Chamorro V; Wangensteen R; Sainz J; Duarte J; O'Valle F; Osuna A; Vargas F
Clin Sci (Lond); 2004 Mar; 106(3):251-9. PubMed ID: 14521506
[TBL] [Abstract][Full Text] [Related]
42. Losartan reduces the increased participation of cyclooxygenase-2-derived products in vascular responses of hypertensive rats.
Alvarez Y; Pérez-Girón JV; Hernanz R; Briones AM; García-Redondo A; Beltrán A; Alonso MJ; Salaices M
J Pharmacol Exp Ther; 2007 Apr; 321(1):381-8. PubMed ID: 17244722
[TBL] [Abstract][Full Text] [Related]
43. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
44. Hypertension impairs postnatal vasculogenesis: role of antihypertensive agents.
You D; Cochain C; Loinard C; Vilar J; Mees B; Duriez M; Lévy BI; Silvestre JS
Hypertension; 2008 Jun; 51(6):1537-44. PubMed ID: 18426993
[TBL] [Abstract][Full Text] [Related]
45. Losartan versus gene therapy: chronic control of high blood pressure in spontaneously hypertensive rats.
Lu D; Raizada MK; Iyer S; Reaves P; Yang H; Katovich MJ
Hypertension; 1997 Sep; 30(3 Pt 1):363-70. PubMed ID: 9314418
[TBL] [Abstract][Full Text] [Related]
46. Discrepant regulation of QT (QTc) interval duration by calcium channel blockade and angiotensin converting enzyme inhibition in experimental hypertension.
Klimas J; Vaja V; Vercinska M; Kyselovic J; Krenek P
Basic Clin Pharmacol Toxicol; 2012 Oct; 111(4):279-88. PubMed ID: 22626243
[TBL] [Abstract][Full Text] [Related]
47. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
[TBL] [Abstract][Full Text] [Related]
48. Long‑term treatment of spontaneously hypertensive rats with losartan and molecular basis of modulating Ito of ventricular myocytes.
Zhang H; Wu S; Huang C; Li X
Mol Med Rep; 2014 May; 9(5):1959-67. PubMed ID: 24584699
[TBL] [Abstract][Full Text] [Related]
49. Apoptosis, myocardial fibrosis and angiotensin II in the left ventricle of hypertensive rats treated with fosinopril or losartan.
Yu G; Liang X; Xie X; Yang T; Sun M; Zhao S
Chin Med J (Engl); 2002 Sep; 115(9):1287-91. PubMed ID: 12411096
[TBL] [Abstract][Full Text] [Related]
50. Calcitonin gene-related peptide-mediated antihypertensive and anti-platelet effects by rutaecarpine in spontaneously hypertensive rats.
Li D; Peng J; Xin HY; Luo D; Zhang YS; Zhou Z; Jiang DJ; Deng HW; Li YJ
Peptides; 2008 Oct; 29(10):1781-8. PubMed ID: 18625276
[TBL] [Abstract][Full Text] [Related]
51. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
Takeda K; Fujita H; Nakamura K; Uchida A; Tanaka M; Itoh H; Nakata T; Sasaki S; Nakagawa M
Blood Press Suppl; 1994; 5():94-8. PubMed ID: 7889211
[TBL] [Abstract][Full Text] [Related]
52. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.
Chung S; Park CW; Shin SJ; Lim JH; Chung HW; Youn DY; Kim HW; Kim BS; Lee JH; Kim GH; Chang YS
Nephrol Dial Transplant; 2010 Feb; 25(2):389-99. PubMed ID: 19749146
[TBL] [Abstract][Full Text] [Related]
53. Effect of N-(biphenylyl-methyl)imidazole, a type 1 angiotensin II receptor inhibitor, on the contractile function of the rat corpus cavernosum.
Tong YC; Wang CJ; Chan P; Cheng JT
Urol Int; 2000; 64(3):149-53. PubMed ID: 10859546
[TBL] [Abstract][Full Text] [Related]
54. Effect of polyphenol-containing azuki bean (Vigna angularis) extract on blood pressure elevation and macrophage infiltration in the heart and kidney of spontaneously hypertensive rats.
Sato S; Mukai Y; Yamate J; Kato J; Kurasaki M; Hatai A; Sagai M
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):43-9. PubMed ID: 18047626
[TBL] [Abstract][Full Text] [Related]
55. Early regression of coronary artery remodeling with esmolol and DDAH/ADMA pathway in hypertensive rats.
Quintana-Villamandos B; Arnalich-Montiel A; Arribas S; Lüneburg N; Böger RH; Delgado-Martos MJ; Fernández-Criado C; Delgado-Baeza E; González MC
Hypertens Res; 2016 Oct; 39(10):692-700. PubMed ID: 27250567
[TBL] [Abstract][Full Text] [Related]
56. Effect of CCL5 on dimethylarginine dimethylaminohydrolase-1 production in vascular smooth muscle cells from spontaneously hypertensive rats.
Kim HY; Kim JH; Kim HS
Cytokine; 2013 Oct; 64(1):227-33. PubMed ID: 23834755
[TBL] [Abstract][Full Text] [Related]
57. Increase of release of neuropeptide Y in vitro from platelets of spontaneously hypertensive rats.
Chen SH; Han QD
Zhongguo Yao Li Xue Bao; 1995 Mar; 16(2):149-52. PubMed ID: 7597917
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of Ang II and renal sympathetic nerve influence dopamine-and isoprenaline-induced renal haemodynamic changes in normal Wistar-Kyoto and spontaneously hypertensive rats.
Abdulla MH; Sattar MA; Abdullah NA; Hazim AI; Anand Swarup KR; Rathore HA; Khan MA; Johns EJ
Auton Autacoid Pharmacol; 2008 Oct; 28(4):95-101. PubMed ID: 18778332
[TBL] [Abstract][Full Text] [Related]
59. Thrombin-induced abnormal platelet activation in spontaneously hypertensive rats is linked with phosphoinositides turnover and phosphorylation of 47,000 and 20,000 dalton proteins.
Huzoor-Akbar ; Anwer K
Thromb Res; 1988 Jan; 49(1):5-21. PubMed ID: 2831638
[TBL] [Abstract][Full Text] [Related]
60. [Changes of endogenous hydrogen sulfide (H2S) in hypertensive rats].
Yan H; Du JB; Tang CS
Zhonghua Er Ke Za Zhi; 2004 Mar; 42(3):172-5. PubMed ID: 15144708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
